An ancient Greek pain remedy for athletes

Pain Practice

Volumn 6, Issue 3, 2006, Pages 212-218

  Bartels, Else M ^a   Swaddling, Judith ^b   Harrison, Adrian P ^c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b BRITISH MUSEUM   (United Kingdom)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Cannabinoids; Ointments; Opioids; Transdermal

Indexed keywords

CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID DERIVATIVE; CROCUS SATIVUS EXTRACT; DRONABINOL; FENTANYL; MORPHINE; NARCOTIC ANALGESIC AGENT; OLYMPIC VICTOR DARK OINTMENT; OPIATE; PLANT EXTRACT; RECREATIONAL DRUG; UNCLASSIFIED DRUG;

ANALGESIA; ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; APATHY; ARTICLE; ATHLETE; BLURRED VISION; CONSCIOUSNESS DISORDER; COORDINATION DISORDER; CULTURAL ANTHROPOLOGY; DOSE RESPONSE; DROWSINESS; DRUG ABSORPTION; DRUG DEPENDENCE; DRUG EFFICACY; DRUG FATALITY; DRUG HALF LIFE; DRUG INTOXICATION; DRUG MECHANISM; DRUG MEGADOSE; DRUG METABOLISM; DRUG SAFETY; DRUG TOLERANCE; DRUG UPTAKE; DRUG WITHDRAWAL; GREECE; HISTORY OF MEDICINE; HUMAN; LETHAL DOSE; LONG TERM CARE; LUNG TUMOR; MENTAL DISEASE; MOOD DISORDER; MUSCLE CRAMP; MUSCLE STIFFNESS; MYDRIASIS; NEUROPATHIC PAIN; NONHUMAN; OCCUPATIONAL DISEASE; OCCUPATIONAL HAZARD; OCCUPATIONAL HEALTH; OINTMENT; PAIN; PHYSICAL DISABILITY; PISTIL STIGMA; POSTOPERATIVE PAIN; RESPIRATION DEPRESSION; RISK ASSESSMENT; SIDE EFFECT; SYNCOPE; THOUGHT DISORDER; TRANSDERMAL PATCH; TREMOR; WEAKNESS;

ANALGESICS; ATHLETIC INJURIES; GREECE; HISTORY, ANCIENT; HUMANS; PAIN; PHYTOTHERAPY; SPORTS;

EID: 33746894112     PISSN: 15307085     EISSN: 15332500     Source Type: Journal    
DOI: 10.1111/j.1533-2500.2006.00088.x     Document Type: Article

References (27)

1. Martin BR, Wiley JL. Mechanism of action of cannabinoids: How it may lead to treatment of cachexia, emesis, and pain. J Support Oncol. 2004; 2: 305-314.
2. Harrison AP, Swaddling J. Ancient Olympic athletes and pain. Pain Pract. 2004. Book of Abstracts - 3rd World Congress, WIP, Barcelona, Spain, 261.
3. Galen of Pergamum. Galeni de Compositione Pharmacorum Book IV. 531. b & c. Omnia Tum Quae Antehac Extabant. 1550: - equivalent to K.G. Kühn, Vol. 12, page 73, Liepzig 1826. Copenhagen University Library, 20 KL. 27355.
4. Warfield CA. A history of pain relief. Hospital Prac. 1988; 23: 121-122.
5. Leake CD. The Old Egyptian Medical Papyri: The Hearst Papyris. Golden, CO: Ares Publishers Inc.; 1995.
6. A. Cornelius Celsus. De Medicina. The Loeb Classical Library, vol. 336, translated by W.G. Spencer. Harvard University Press, ISBN 0-674-99370-5, 1938.
7. Gunther RT. The Greek Herbal of Dioscorides, Illustrated by a Byzantine ad 512, Englished by John Goodyer ad 1655. New York: Hafner Publishing Co; 1959.
8. Pliny G. Natural History - Book XX. LCL 392. The Loeb Classical Library, Vol. 6, translated by W.A.S. Jones, Harvard University Press, ISBN 0-674-99431-0, 1951.
9. Menahem S, Shvartzman P. High-dose fentanyl patch for cancer pain. JAm Board Fam Pract. 2004; 17: 388-390.
10. Bleeker CP, Bremer RC, Dongelmans DA, van Dongen RTM, Crul BJ. Inefficacy of high-dose transdermal fentanyl in a patient with neuropathic pain: A case report. Eur J Pain. 2001; 5: 325-329.
11. Greene SL, Dargan PI, Jones AL. Acute poisoning: Understanding 90% of cases in a nutshell. Postgrad Med J. 2005; 81: 204-216.
12. Piomelli D. The molecular logic of endocannabinoid signalling. Nat Rev Neurosci. 2003; 4: 873-884.
13. Atta-ur-Rahman AU, Naz H, Fadimatou, et al. Bioactive constituents from Boswellia papyrifera. J Nat Prod. 2005; 68: 189-193.
14. Moussaieff A, Bregman T. Incensole Acetate: A Psycho-Active Compound Derived from Frankincense, with a Partial Cannabimimetic Profile. Clearwater, FL: XV Symposium on the Cannabinoids; 2005: 89.
15. Hall W, Christie M, Currow D. Cannabinoids and cancer: Causation, remediation, and palliation. Lancet. 2005; 6: 35-42.
16. Nutton V. Ancient Medicine. London: Routledge; 2004. ISBN 0-415-08611-6.
17. Gilman AG, Rall TW, Nies AS, Taylor P (eds). Goodman and Gilman's The Pharmacological Basis of Therapeutics. New York: Pergamon Press; 1990; ISBN 0-08-040296-8.
18. Pless P, Leson G. Assessing the impact of THC uptake from hemp oil cosmetics on workplace drug testing. 2001. Leson Environmental Consulting, PO Box 10075, Berkeley, CA, 94709. http://66.249.93.104/search?q=cache:SM0N0KS6ygYJ:www.votehemp.com/PDF/ Transdermal_THC_final.PDF+pless+P+and+leson+G&hl=en&ct= clnk&cd=10&client=safari
19. Touitou E, Fabin B, Dany S, Almog S. Transdermal delivery of tetrahydrocannabinol. Int J. Pharm. 1988; 43: 9-15.
20. Hosseinzadeh H, Younesi HM. Antinociceptive and anti-inflammatory effects of Crocus sativus L. Stigma and petal extracts in mice. BMC Pharmacol. 2002; 2: 7-14.
21. Foley KM. The treatment of cancer pain. N. Engl. J. Med. 1985; 313: 84-95.
22. Gnielinski M, Adams HA. Perioperative Schmerztherapie bei Traumapatienten. Unfallchirug. 2004; 107: 92-98.
23. Rottach KG, Wohlgemuth WA, Dzaja AE, Eggert T, Straube A. Effects of intravenous opioids on eye movements in humans: possible mechanisms. J. Neurol. 2002; 249: 1200-1205.
24. Logan BK, Oliver JS, Smith H. The measurement and interpretation of morphine in blood. Forensic Sci Int. 1987; 35: 189-195.
25. Hanks GW, Reid C. Contribution to variability in response to opioids. Support Care Cancer. 2005; 13: 145-152.
26. Trujillo KA, Kubota KS, Warmoth KP. Continuous administration of opioids produces locomotor sensitization. Pharmacology, Biochem Behav. 2004; 79: 661-669.
27. Robinson TE, Berridge KC. Addiction. Annu Rev Psychol. 2003; 54: 25-53.